Machine learning

AI brain
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #EMA #Machine learning

EMA urges “human-centric approach” to AI in drug discovery

The European Medicines Association (EMA) has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of medicines. The paper, which is now open for public consultation, reflects on principles… Read More

#News #Regulatory

Big data concept image
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Data science #Machine learning

Big data – charting a new path to drug discovery and development

Listen to this article on the DDW Podcast: Tim Lowery, President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. Read More

#Exclusive Content

#Artificial intelligence (AI) #Cell and gene therapy #Machine learning #Monoclonal antibodies #mRNA #Precision medicine

Right on target: The shift to precision pharmaceuticals

By DDW Editor Reece Armstrong. If there’s one thing I would take from the Summer 2023 issue of Drug Discovery World, it would be that the application of technologies and processes throughout the pharmaceutical industry are changing how scientists pursue the development of… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Covid-19 #Genomics #Machine learning #Microfluidics

New podcast: Reaching new heights with drug discovery

This is the latest episode of the free DDW narrated podcast, “Reaching new heights with drug discovery”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “High-throughput technologies: Reaching for the stars” and “… Read More

#News

MRI image
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Imaging #Machine learning

Avoid the five stumbling blocks for working with medical imaging

How can you reduce timelines for R&D? Tackle your enterprise’s siloed and disorganised imaging data. Maximise the value of data in your archives and stop spending weeks on mundane data-wrangling tasks. We’ve compiled a list of the top five stumbling blocks for working with medical imaging. This… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Imaging #Machine learning

5 reasons your organisation needs a modern medical imaging infrastructure

How can you reduce timelines for R&D? Tackle your enterprise’s siloed and disorganised imaging data. Maximise the value of data in your archives and stop spending weeks on mundane data-wrangling tasks. We’ve compiled a list of the top 5 stumbling blocks for working with medical imaging. This whitepaper digs into… Read More

#Resources

PanHunter
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Case study #Evotec #Machine learning #Multi-omics #Omics #Software

Case study: The PanHunter multi-omics analysis platform

A new Case Study is available, sponsored by Evotec. The study of health and disease through multi-omics research generates vast amounts of interconnected data. Unlocking their secrets requires complex bioinformatic exploration. This analysis is accelerated by a dedicated and flexible software application that is not only reliable and provides… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning #Multi-omics #Omics #Software

PanHunter: Your enterprise solution to find the detail that matters

The study of health and disease through multi-omics research generates vast amounts of interconnected data. Unlocking their secrets requires complex bioinformatic exploration. This analysis is accelerated by a dedicated and flexible software application that is not only reliable and provides reproducible results, but also facilitates collaboration between project investigators… Read More

#Resources

Artificial intelligence
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Benchling #Cancer research #Drug discovery #Machine learning #Rare disease

Latest eBook: AI and drug development

The latest eBook by DDW is out now. This 28-page eBook, sponsored by Benchling, examines the ways in which artificial intelligence and machine learning are expediting drug discovery efforts. Download this exclusive eBook to learn more about: The latest advancements in artificial intelligence… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Benchling #Cancer research #Drug discovery #Machine learning #Rare disease

AI and drug development: Using AI and machine learning to expedite drug discovery

This latest eBook sponsored by Benchling features insight on how artificial intelligence is helping advance drug discovery efforts. Download this exclusive eBook to learn more about: The latest advancements in artificial intelligence How machine learning is being used across cancer research Why AI is critical to solving challenges in drug… Read More

#DDW eBooks #Intelligence

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Benchling #Data standardisation #Machine learning

Want to be ready to implement AI and ML in biotech? Start with your data

This article is sponsored by Benchling. “What’s the single most important factor when building a machine learning model? Data! Having the right data, and an understanding of the uncertainty in that data often makes the difference between useful and useless models,” said Pat Walters, Chief Data… Read More

#News

Artificial intelligence
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Drug targets #Machine learning

Can artificial intelligence help craft new medicines?

Listen to this article on the DDW Podcast: Professor Sonika Bhatnagar explores how artificial intelligence is enabling drug discovery at rates never seen before. A bullet for cure The year was 1907, and Paul Ehrlich, the German Nobel laureate had proposed the idea of… Read More

#Exclusive Content

Histology slides
#AACR 2023 #AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cancer research #Machine learning #Oncology

AI can predict the risk of distant recurrence in endometrial cancer

An investigational deep learning model requiring one histopathologic slide accurately predicted the risk of distant recurrence in patients with endometrial cancer, according to findings presented at the AACR Annual Meeting 2023. Endometrial cancer is the most common type of uterine cancer. While patients with early-stage uterine… Read More

#Cancer Research #News #Trending News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Atomic AI #Machine learning #Molecular Biology #RNA

Using AI to design RNA-based medicines

US-based start-up Atomic AI is using artificial intelligence (AI) to design more intelligent RNA-targeted and RNA-based medicines. Diana Spencer spoke to Raphael Townshend, PhD, Founder and CEO of Atomic AI, about the advantages of combining two such exciting technologies. Artificial Intelligence (AI) has been enthusiastically adopted… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Contract Research Organisations (CROs) #Machine learning #Rare disease #Rare Disease Day

How AI can be utilised to improve rare disease drug development

By Lucy Radley, Head of EU Regulatory Development, ProPharma. A rare disease is defined as a condition which affects less than one in 2000 people. Although individually they are very rare, collectively they are common with one in 17 people (around 3.5 million) in the UK being affected… Read More

#Exclusive Content #Opinion

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #Drug discovery #Machine learning #Medicinal chemistry #Webinar

Connected chemistry: Choose the most promising drug candidates

DDW is hosting an exclusive free event, Connected chemistry: How to choose the most promising drug candidates from your hit list. It will be supported by Torx Software. It will take place on March 8, 2023 3PM GMT. Register here for free. AI and machine learning (AI/ML)… Read More

Webinar date:
#News